TNK BIOTECH ApS: Financial statements 2016
CVR: 30691911
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
TNK BIOTECH ApS (CVR 30691911) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -9,548 and a net result of DKK -11,322 compared with DKK -40,518 the year before. Equity in the 2016 report amounted to DKK 36,516. The solvency ratio was 82%.
- Gross Profit
- DKK -9,548
- Profit/Loss
- DKK -11,322
- Equity
- DKK 36,516
- Total Assets
- DKK 44,516
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -10 t. | -11 t. | 37 t. | - |
| 2015 | - | -32 t. | -41 t. | 48 t. | - |
| 2014 | - | -8 t. | -11 t. | 88 t. | - |
| 2013 | - | 269 t. | 75 t. | 99 t. | - |
| 2012 | - | - | - | - | - |
Official annual report
Find more companies like TNK BIOTECH ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
TNK BIOTECH ApS has published its annual report for 2015. Gross profit came to DKK -32,465, and the net result was DKK -40,518.
About TNK BIOTECH ApS
TNK BIOTECH ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2007. The company is registered under the industry Investering for egen regning. The company was previously named TNK INVEST ApS. The management consists of Thomas Nitschke Kledal. The company is owned by Thomas Nitschke Kledal. The company has 0 employees (2013). In 2025, the company reported a gross profit of DKK -11,363 and a net result of DKK -17,528 compared with DKK -15,724 the year before. Equity in the 2025 report amounted to DKK -82,154.